{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:29:40Z","timestamp":1720484980764},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejim.2016.08.031","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T16:42:40Z","timestamp":1473439360000},"page":"e24-e25","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Additional clinical benefit independent of study result or trial arm allocation to participants in multi-center randomized controlled trials"],"prefix":"10.1016","volume":"36","author":[{"given":"Shaul","family":"Atar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejim.2016.08.031_bb0005","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/bjc.2013.113","article-title":"Drivers and barriers to patient participation in RCTs","volume":"108","author":"Jenkins","year":"2013","journal-title":"Br J Cancer"},{"issue":"7191","key":"10.1016\/j.ejim.2016.08.031_bb0010","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.318.7191.1114","article-title":"Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study","volume":"318","author":"Welton","year":"1999","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ejim.2016.08.031_bb0015","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial","volume":"312","author":"O'Donoghue","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ejim.2016.08.031_bb0020","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/1097-0142(19851001)56:7<1710::AID-CNCR2820560741>3.0.CO;2-T","article-title":"Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials","volume":"56","author":"Davis","year":"1985","journal-title":"Cancer"},{"issue":"9405","key":"10.1016\/j.ejim.2016.08.031_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)15383-4","article-title":"Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review","volume":"363","author":"Peppercorn","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejim.2016.08.031_bb0030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/sj.bjc.6604982","article-title":"Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials","volume":"100","author":"Tanai","year":"2009","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ejim.2016.08.031_bb0035","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/0735-1097(96)00018-6","article-title":"Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison","volume":"27","author":"Jha","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2016.08.031_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJM200507073530117","article-title":"Intensive lipid lowering with atorvastatin in coronary disease","volume":"353","author":"Cannon","year":"2005","journal-title":"N Engl J Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516302965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620516302965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T19:45:50Z","timestamp":1531597550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620516302965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":8,"alternative-id":["S0953620516302965"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2016.08.031","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Additional clinical benefit independent of study result or trial arm allocation to participants in multi-center randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2016.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}